Found: 247
Select item for more details and to access through your institution.
Clinical Features of Regorafenib-induced Liver Injury in Japanese Patients From Postmarketing Experience.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Impact of omitting fluorouracil from FOLFIRI plus bevacizumab as second-line chemotherapy for patients with metastatic colorectal cancer.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 3, p. 1123, doi. 10.1007/s00432-022-03979-2
- By:
- Publication type:
- Article
A phase 3 non-inferiority study of 5-FU/ l-leucovorin/irinotecan (FOLFIRI) versus irinotecan/S-1 (IRIS) as second-line chemotherapy for metastatic colorectal cancer: updated results of the FIRIS study.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2015, v. 141, n. 1, p. 153, doi. 10.1007/s00432-014-1783-3
- By:
- Publication type:
- Article
Progression-free survival and post-progression survival in patients with advanced gastric cancer treated with first-line chemotherapy.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2013, v. 139, n. 8, p. 1383, doi. 10.1007/s00432-013-1452-y
- By:
- Publication type:
- Article
Validation study of a prognostic classification in patients with metastatic colorectal cancer who received irinotecan-based second-line chemotherapy.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2013, v. 139, n. 4, p. 595, doi. 10.1007/s00432-012-1349-1
- By:
- Publication type:
- Article
A phase 1b study of andecaliximab in combination with S-1 plus platinum in Japanese patients with gastric adenocarcinoma.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-13801-1
- By:
- Publication type:
- Article
Phase II study of cetuximab plus S-1/cisplatin therapy in Japanese patients with advanced gastric cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2021, v. 51, n. 6, p. 879, doi. 10.1093/jjco/hyaa276
- By:
- Publication type:
- Article
Post-marketing surveillance study of trifluridine/tipiracil in patients with metastatic colorectal cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2021, v. 51, n. 5, p. 700, doi. 10.1093/jjco/hyaa243
- By:
- Publication type:
- Article
Observational study of first-line chemotherapy including cetuximab in patients with metastatic colorectal cancer: CORAL trial.
- Published in:
- Japanese Journal of Clinical Oncology, 2019, v. 49, n. 4, p. 339, doi. 10.1093/jjco/hyy189
- By:
- Publication type:
- Article
A Phase 1/1b tolerability study of rilotumumab alone or in combination with cisplatin and capecitabine in Japanese patients with gastric cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2017, v. 47, n. 11, p. 1002, doi. 10.1093/jjco/hyx114
- By:
- Publication type:
- Article
Comparison between neoadjuvant chemotherapy followed by surgery and definitive chemoradiotherapy for overall survival in patients with clinical Stage II/III esophageal squamous cell carcinoma (JCOG1406-A).
- Published in:
- Japanese Journal of Clinical Oncology, 2017, v. 47, n. 6, p. 480, doi. 10.1093/jjco/hyx040
- By:
- Publication type:
- Article
Clinical outcome of definitive radiation therapy for superficial esophageal cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2017, v. 47, n. 5, p. 393, doi. 10.1093/jjco/hyx021
- By:
- Publication type:
- Article
Phase 1 study of ombrabulin in combination with cisplatin (CDDP) in Japanese patients with advanced solid tumors.
- Published in:
- Japanese Journal of Clinical Oncology, 2016, v. 46, n. 11, p. 1000, doi. 10.1093/jjco/hyw122
- By:
- Publication type:
- Article
A short interval between bevacizumab and anti-epithelial growth factor receptor therapy interferes with efficacy of subsequent anti-EGFR therapy for refractory colorectal cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2016, v. 46, n. 3, p. 228, doi. 10.1093/jjco/hyv193
- By:
- Publication type:
- Article
Panitumumab in Japanese Patients with Unresectable Colorectal Cancer: A Post-marketing Surveillance Study of 3085 Patients.
- Published in:
- Japanese Journal of Clinical Oncology, 2014, v. 44, n. 2, p. 214, doi. 10.1093/jjco/hyt196
- By:
- Publication type:
- Article
Time-dependent discrepancies between physician-assessed and patient-reported oxaliplatin-induced peripheral neuropathy in patients with metastatic colorectal cancer who received mFOLFOX6 plus bevacizumab: a post hoc analysis (WJOG4407GSS2).
- Published in:
- 2021
- By:
- Publication type:
- journal article
A randomized controlled trial of surgery and postoperative modified FOLFOX6 versus surgery and perioperative modified FOLFOX6 plus cetuximab in patients with KRAS wild-type resectable colorectal liver metastases: EXPERT study.
- Published in:
- Langenbeck's Archives of Surgery, 2022, v. 407, n. 4, p. 1345, doi. 10.1007/s00423-022-02434-7
- By:
- Publication type:
- Article
Prognostic impact of shift to low visceral fat mass after neoadjuvant chemotherapy in patients with esophageal cancer.
- Published in:
- Cancer Reports, 2024, v. 7, n. 8, p. 1, doi. 10.1002/cnr2.2084
- By:
- Publication type:
- Article
Prognostic Impact of Sarcopenic Obesity after Neoadjuvant Chemotherapy Followed by Surgery in Elderly Patients with Esophageal Squamous Cell Carcinoma.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 9, p. 2974, doi. 10.3390/jcm9092974
- By:
- Publication type:
- Article
Prognostic Significance of Sarcopenia in Patients with Unresectable Advanced Esophageal Cancer.
- Published in:
- Journal of Clinical Medicine, 2019, v. 8, n. 10, p. 1647, doi. 10.3390/jcm8101647
- By:
- Publication type:
- Article
'Para-lesional' Saline Injection Method for Assessment of Small Gastric Cancers by Endoscopic Ultrasonography.
- Published in:
- Digestive Endoscopy, 1996, v. 8, n. 2, p. 122, doi. 10.1111/j.1443-1661.1996.tb00427.x
- By:
- Publication type:
- Article
Chronological improvement of survival in patients with advanced gastric cancer over 15 years.
- Published in:
- Therapeutic Advances in Medical Oncology, 2024, p. 1, doi. 10.1177/17588359241229428
- By:
- Publication type:
- Article
European-Australasian consensus on the management of advanced gastric and gastro-oesophageal junction cancer: current practice and new directions.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221118874
- By:
- Publication type:
- Article
Long-Term Outcome of Patients with Locally Advanced Clinically Unresectable Esophageal Cancer Undergoing Conversion Surgery after Induction Chemotherapy with Docetaxel Plus Cisplatin and 5-Fluorouracil.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2021, v. 28, n. 2, p. 712, doi. 10.1245/s10434-020-08865-0
- By:
- Publication type:
- Article
A Multicenter Phase II Trial of mFOLFOX6 Plus Bevacizumab to Treat Liver-Only Metastases of Colorectal Cancer that are Unsuitable for Upfront Resection (TRICC0808).
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2015, v. 22, n. 3, p. 908, doi. 10.1245/s10434-014-4094-7
- By:
- Publication type:
- Article
Protocol of the QUATTRO-II study: a multicenter randomized phase II study comparing CAPOXIRI plus bevacizumab with FOLFOXIRI plus bevacizumab as a first-line treatment in patients with metastatic colorectal cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Weekly paclitaxel plus ramucirumab versus weekly nab-paclitaxel plus ramucirumab for unresectable advanced or recurrent gastric cancer with peritoneal dissemination refractory to first-line therapy-the P-SELECT trial (WJOG10617G)-a randomised phase II trial by the West Japan Oncology Group.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Retrospective observational study of salvage line ramucirumab monotherapy for patients with advanced gastric cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Efficacy of trastuzumab emtansine in Japanese patients with previously treated HER2‐positive locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma: A subgroup analysis of the GATSBY study.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2020, v. 16, n. 1, p. 5, doi. 10.1111/ajco.13243
- By:
- Publication type:
- Article
A phase II trial of prophylactic olanzapine combined with palonosetron and dexamethasone for preventing nausea and vomiting induced by cisplatin.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2016, v. 12, n. 3, p. 254, doi. 10.1111/ajco.12489
- By:
- Publication type:
- Article
Combination therapy of capecitabine, irinotecan, oxaliplatin, and bevacizumab as a first‐line treatment for metastatic colorectal cancer: Safety lead‐in results from the QUATTRO-II study.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 6, p. 1649, doi. 10.1007/s10637-021-01125-2
- By:
- Publication type:
- Article
A phase I study of ontuxizumab, a humanized monoclonal antibody targeting endosialin, in Japanese patients with solid tumors.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 5, p. 1061, doi. 10.1007/s10637-018-0713-7
- By:
- Publication type:
- Article
Durable response to the ALK inhibitor alectinib in inflammatory myofibroblastic tumor of the head and neck with a novel SQSTM1–ALK fusion: a case report.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 4, p. 791, doi. 10.1007/s10637-019-00742-2
- By:
- Publication type:
- Article
Risk factors affecting delay of initiating adjuvant chemotherapy for stage III colorectal cancer.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 9, p. 1293, doi. 10.1007/s10147-024-02567-3
- By:
- Publication type:
- Article
Survival impact of sequential chemotherapy following pembrolizumab for recurrent or metastatic head and neck squamous cell carcinoma.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 6, p. 764, doi. 10.1007/s10147-024-02508-0
- By:
- Publication type:
- Article
Trastuzumab deruxtecan in patients with locally advanced or metastatic HER2-positive gastric cancer: a multicenter, open-label, expanded-access study.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 1, p. 27, doi. 10.1007/s10147-023-02422-x
- By:
- Publication type:
- Article
Nivolumab versus irinotecan as third- or later-line treatment for advanced gastric cancer: a multi-center retrospective study.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 6, p. 756, doi. 10.1007/s10147-023-02330-0
- By:
- Publication type:
- Article
Regulation of MEK inhibitor selumetinib sensitivity by AKT phosphorylation in the novel BRAF L525R mutant.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 5, p. 654, doi. 10.1007/s10147-023-02318-w
- By:
- Publication type:
- Article
Clinical outcomes of patients diagnosed with cancer of unknown primary or malignancy of undefined primary origin who were referred to a regional cancer center.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 5, p. 644, doi. 10.1007/s10147-023-02316-y
- By:
- Publication type:
- Article
Phase I study of napabucasin in combination with FOLFIRI + bevacizumab in Japanese patients with metastatic colorectal cancer.
- Published in:
- International Journal of Clinical Oncology, 2021, v. 26, n. 11, p. 2017, doi. 10.1007/s10147-021-01987-9
- By:
- Publication type:
- Article
Infusion-related reaction to ramucirumab plus FOLFIRI in patients with advanced colorectal cancer.
- Published in:
- International Journal of Clinical Oncology, 2021, v. 26, n. 11, p. 2025, doi. 10.1007/s10147-021-02004-9
- By:
- Publication type:
- Article
A triplet combination of FOLFOXIRI plus cetuximab as first-line treatment in RAS wild-type, metastatic colorectal cancer: a dose-escalation phase Ib study.
- Published in:
- International Journal of Clinical Oncology, 2021, v. 26, n. 4, p. 701, doi. 10.1007/s10147-020-01842-3
- By:
- Publication type:
- Article
Second-line chemotherapy using taxane in patients with advanced gastric cancer who presented with severe peritoneal metastasis: a multicenter retrospective study.
- Published in:
- International Journal of Clinical Oncology, 2021, v. 26, n. 2, p. 355, doi. 10.1007/s10147-020-01802-x
- By:
- Publication type:
- Article
Pertuzumab plus trastuzumab and chemotherapy for Japanese patients with HER2-positive metastatic gastric or gastroesophageal junction cancer: a subgroup analysis of the JACOB trial.
- Published in:
- International Journal of Clinical Oncology, 2020, v. 25, n. 2, p. 301, doi. 10.1007/s10147-019-01558-z
- By:
- Publication type:
- Article
Japan Society of Clinical Oncology provisional clinical opinion for the diagnosis and use of immunotherapy in patients with deficient DNA mismatch repair tumors, cooperated by Japanese Society of Medical Oncology, First Edition.
- Published in:
- International Journal of Clinical Oncology, 2020, v. 25, n. 2, p. 217, doi. 10.1007/s10147-019-01498-8
- By:
- Publication type:
- Article
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer.
- Published in:
- International Journal of Clinical Oncology, 2020, v. 25, n. 1, p. 1, doi. 10.1007/s10147-019-01485-z
- By:
- Publication type:
- Article
Systemic chemotherapy for gastric cancer with early recurrence after adjuvant S-1 monotherapy: a multicenter retrospective study.
- Published in:
- International Journal of Clinical Oncology, 2019, v. 24, n. 10, p. 1197, doi. 10.1007/s10147-019-01477-z
- By:
- Publication type:
- Article
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer.
- Published in:
- International Journal of Clinical Oncology, 2018, v. 23, n. 1, p. 1, doi. 10.1007/s10147-017-1101-6
- By:
- Publication type:
- Article
Comparison between surgery and definitive chemoradiotherapy for patients with resectable esophageal squamous cell carcinoma: a propensity score analysis.
- Published in:
- International Journal of Clinical Oncology, 2016, v. 21, n. 5, p. 890, doi. 10.1007/s10147-016-0963-3
- By:
- Publication type:
- Article
Differences in attitude toward adjuvant chemotherapy between colorectal cancer survivors and the medical staff of Japanese hospitals.
- Published in:
- International Journal of Clinical Oncology, 2015, v. 20, n. 4, p. 755, doi. 10.1007/s10147-014-0772-5
- By:
- Publication type:
- Article